Showing results (1231-1240 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancerMari Nakabayashi, Jonathan Ling, Wanling Xie, et al.Cancer Journal (Sudbury, Mass.)|June 5, 2020
Role of Microenvironment in Non-Hodgkin Lymphoma: Understanding the Composition and BiologyArushi Khurana, Stephen M AnsellCancer Journal (Sudbury, Mass.)|June 5, 2020
Central Nervous System Lymphoma: Approach to Diagnosis and TreatmentCarlos Eduardo Correia, Lauren R Schaff, Christian GrommesCancer Journal (Sudbury, Mass.)|August 16, 2021
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic ImplicationsRiccardo Moia, Andrea Patriarca, Mattia Schipani, et al.Cancer Journal (Sudbury, Mass.)|August 16, 2021
Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted TherapiesNil Albiol, Carol MorenoCancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.Cancer Journal (Sudbury, Mass.)|November 9, 2004
A clinician's guide to hereditary colon cancerEllen T Matloff, Karina L Brierley, Christina M ChimeraCancer Journal (Sudbury, Mass.)|February 11, 2005
Radiotherapy for the clinically negative neck in supraglottic laryngeal cancerTracy E Alpert, Stefania Morbidini-Gaffney, Chung T Chung, et al.Cancer Journal (Sudbury, Mass.)|February 11, 2005
Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppressionMatthew C Solhjem, Brian J Davis, Thomas M Pisansky, et al.Cancer Journal (Sudbury, Mass.)|February 11, 2005
Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D3S Packianathan, Rajendra G Mehta, Rajeshwari R Mehta, et al.Pageof 160